Form 8-K - Current report:
SEC Accession No. 0001641172-25-002088
Filing Date
2025-04-01
Accepted
2025-04-01 16:30:10
Documents
15
Period of Report
2025-03-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39831
2 ex23-1.htm EX-23.1 4521
  Complete submission text file 0001641172-25-002088.txt   254560

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cocp-20250331.xsd EX-101.SCH 3281
4 XBRL DEFINITION FILE cocp-20250331_def.xml EX-101.DEF 26194
5 XBRL LABEL FILE cocp-20250331_lab.xml EX-101.LAB 35961
6 XBRL PRESENTATION FILE cocp-20250331_pre.xml EX-101.PRE 24822
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4325
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 25800156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)